Our previous study [11] showed BMP9 was significantly reduced in NAFLD mice, and supplement of BMP9 improved NAFLD by downregulating the expression of genes related to glucometabolism and lipometabolism, thereby reducing liver inflammation. This evidence concerns the gene GDF2 and metabolic dysfunction-associated steatotic liver disease.